Optimal duration of adjuvant chemotherapy for high-risk node-negative (N–) breast cancer patients: 6-year results of the prospective randomised multicentre phase III UNICANCER-PACS 05 trial (UCBG-0106)
Titel:
Optimal duration of adjuvant chemotherapy for high-risk node-negative (N–) breast cancer patients: 6-year results of the prospective randomised multicentre phase III UNICANCER-PACS 05 trial (UCBG-0106)
Auteur:
Kerbrat, Pierre Desmoulins, Isabelle Roca, Lise Levy, Christelle Lortholary, Alain Marre, Alain Delva, Rémy Rios, Maria Viens, Patrice Brain, Étienne Serin, Daniel Edel, Magali Debled, Marc Campone, Mario Mourret-Reynier, Marie-Ange Bachelot, Thomas Foucher-Goudier, Marie-Josèphe Asselain, Bernard Lemonnier, Jérôme Martin, Anne-Laure Roché, Henri